Cargando…
Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
Sporadic Creutzfeldt-Jakob disease (sCJD) is the commonest human prion disease, occurring most likely as the consequence of spontaneous formation of abnormal prion protein in the central nervous system (CNS). Variant Creutzfeldt–Jakob disease (vCJD) is an acquired prion disease that was first identi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882550/ https://www.ncbi.nlm.nih.gov/pubmed/33532912 http://dx.doi.org/10.1007/s00401-021-02270-x |
_version_ | 1783651072698482688 |
---|---|
author | Douet, Jean-Yves Huor, Alvina Cassard, Hervé Lugan, Séverine Aron, Naima Arnold, Mark Vilette, Didier Torres, Juan-Maria Ironside, James W. Andreoletti, Olivier |
author_facet | Douet, Jean-Yves Huor, Alvina Cassard, Hervé Lugan, Séverine Aron, Naima Arnold, Mark Vilette, Didier Torres, Juan-Maria Ironside, James W. Andreoletti, Olivier |
author_sort | Douet, Jean-Yves |
collection | PubMed |
description | Sporadic Creutzfeldt-Jakob disease (sCJD) is the commonest human prion disease, occurring most likely as the consequence of spontaneous formation of abnormal prion protein in the central nervous system (CNS). Variant Creutzfeldt–Jakob disease (vCJD) is an acquired prion disease that was first identified in 1996. In marked contrast to vCJD, previous investigations in sCJD revealed either inconsistent levels or an absence of PrP(Sc) in peripheral tissues. These findings contributed to the consensus that risks of transmitting sCJD as a consequence of non-CNS invasive clinical procedures were low. In this study, we systematically measured prion infectivity levels in CNS and peripheral tissues collected from vCJD and sCJD patients. Unexpectedly, prion infectivity was detected in a wide variety of peripheral tissues in sCJD cases. Although the sCJD infectivity levels varied unpredictably in the tissues sampled and between patients, these findings could impact on our perception of the possible transmission risks associated with sCJD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02270-x. |
format | Online Article Text |
id | pubmed-7882550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-78825502021-02-25 Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients Douet, Jean-Yves Huor, Alvina Cassard, Hervé Lugan, Séverine Aron, Naima Arnold, Mark Vilette, Didier Torres, Juan-Maria Ironside, James W. Andreoletti, Olivier Acta Neuropathol Original Paper Sporadic Creutzfeldt-Jakob disease (sCJD) is the commonest human prion disease, occurring most likely as the consequence of spontaneous formation of abnormal prion protein in the central nervous system (CNS). Variant Creutzfeldt–Jakob disease (vCJD) is an acquired prion disease that was first identified in 1996. In marked contrast to vCJD, previous investigations in sCJD revealed either inconsistent levels or an absence of PrP(Sc) in peripheral tissues. These findings contributed to the consensus that risks of transmitting sCJD as a consequence of non-CNS invasive clinical procedures were low. In this study, we systematically measured prion infectivity levels in CNS and peripheral tissues collected from vCJD and sCJD patients. Unexpectedly, prion infectivity was detected in a wide variety of peripheral tissues in sCJD cases. Although the sCJD infectivity levels varied unpredictably in the tissues sampled and between patients, these findings could impact on our perception of the possible transmission risks associated with sCJD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02270-x. Springer Berlin Heidelberg 2021-02-02 2021 /pmc/articles/PMC7882550/ /pubmed/33532912 http://dx.doi.org/10.1007/s00401-021-02270-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Douet, Jean-Yves Huor, Alvina Cassard, Hervé Lugan, Séverine Aron, Naima Arnold, Mark Vilette, Didier Torres, Juan-Maria Ironside, James W. Andreoletti, Olivier Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients |
title | Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients |
title_full | Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients |
title_fullStr | Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients |
title_full_unstemmed | Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients |
title_short | Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients |
title_sort | wide distribution of prion infectivity in the peripheral tissues of vcjd and scjd patients |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882550/ https://www.ncbi.nlm.nih.gov/pubmed/33532912 http://dx.doi.org/10.1007/s00401-021-02270-x |
work_keys_str_mv | AT douetjeanyves widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients AT huoralvina widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients AT cassardherve widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients AT luganseverine widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients AT aronnaima widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients AT arnoldmark widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients AT vilettedidier widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients AT torresjuanmaria widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients AT ironsidejamesw widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients AT andreolettiolivier widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients |